Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. - Jardine MJ; Kotwal SS; Bassi A; Hockham C; Jones M; Wilcox A; Pollock C; Burrell LM; McGree J; Rathore V; Jenkins CR; Gupta L; et al. (BMJ (Clinical research ed.), 2022)